Adolescents with full or subthreshold anorexia nervosa in a naturalistic sample: treatment interventions and patient satisfaction.
Katarina Lindstedt, Emma Forss, Marie Elwin...
https://pubmed.ncbi.nlm.nih.gov/32391079Actively Recruiting
Led by Charite University, Berlin, Germany · Updated on 2025-02-13
200
Participants Needed
1
Research Sites
39 weeks
Total Duration
C
Charite University, Berlin, Germany
Lead Sponsor
B
Bielefeld University
Collaborating Sponsor
Researchers are comparing two treatments for adolescents with anorexia nervosa to see which is more effective and cost-efficient. The study focuses on family-based treatment delivered through telehealth (FBT) versus inpatient multimodal therapy (IMT) in specialized hospitals. The results aim to influence future guidelines and insurance coverage for these therapies in Germany. The study is funded by the German Ministry of Health and involves multiple hospitals and public health insurance companies. Participants will receive either family-based therapy via telemedicine, where parents play a central role in supporting their child through three phases of treatment, or inpatient multimodal therapy that includes individual and family psychotherapy, nutritional counseling, body-oriented therapy, group sessions, relaxation, mindfulness, and skills training. The inpatient therapy targets a weight gain of at least 500 grams per week. The FBT typically lasts about 10 months, while the inpatient treatment averages 4 months, with follow-up assessments up to 12 months. During the study, participants will be monitored for changes in weight relative to expected body mass index over 12 months. Additional assessments include eating disorder symptoms, compulsive exercise, depression, menstrual status, medication use, motivation for change, illness insight, quality of life, treatment satisfaction, suicidality, and healthcare costs. Evaluations occur at the start, end of treatment, and at 6 and 12 months after baseline. The study involves regular questionnaires and health economic data collection to carefully track outcomes and safety over the year-long period.
CONDITIONS
Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for screening and enrollment
Duration - Approximately 10 months
Participants receive family-based treatment (FBT) via telemedicine, involving three phases focusing on parental responsibility and gradual transfer to the patient for eating behaviors and individual developmental issues.
Regular telemedicine sessions as scheduled by therapists
Duration - Approximately 4 months
Participants undergo inpatient multimodal therapy including individual psychotherapy, family sessions, body-oriented therapy, nutritional counseling, group therapy, relaxation techniques, mindfulness, and skills training aiming for targeted weight gain.
Multiple visits daily as part of inpatient care
Duration - Up to 12 months from baseline
Participants are monitored up to 12 months from baseline for changes in health status, psychological outcomes, and quality of life after treatment completion.
Assessment visits at 6 months and 12 months after baseline
Total: 1 location
1
Charité- Universitätsmedizin Berlin
Berlin, State of Berlin, Germany, 13353
Actively Recruiting
V
Verena K. Haas, Dr. oec. troph.
P
Piet E. Adler, M.Sc.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Katarina Lindstedt, Emma Forss, Marie Elwin...
https://pubmed.ncbi.nlm.nih.gov/32391079Verena Haas, Katja Wechsung, Vivien Kaiser...
https://pubmed.ncbi.nlm.nih.gov/38082440